期刊文献+

基质金属蛋白酶2和9在膀胱移行细胞癌中的表达及其意义 被引量:2

Correlation of expressions of MMP-2 and MMP-9 in the transitional cell carcinoma of bladder with tumor invasion and metastasis
原文传递
导出
摘要 目的探讨膀胱肿瘤组织中基质蛋白酶-2(MMP-2)及基质蛋白酶-9(MMP-9)的表达与膀胱移行细胞癌(TCCB)侵袭转移的关系。方法选择新乡医学院第一附属医院2006年8月至2008年8月间行TCCB切除术后患者46例作为试验组,并取14例癌旁正常组织(肿瘤周围3~5cm)作为对照组。采用免疫组织化学(EliVision法)检测MMP-2及MMP-9在膀胱肿瘤组织中的表、达。结果MMP-2和MMP-9在TCCB中的表达显著高于癌旁正常组织(P〈0.01),Ⅱ、Ⅲ级TCCB中的阳性表达明显高于I级(P〈0.01);浸润性及Ⅲ级TCCB组织中的阳性表达高于浅表性及Ⅱ级中的表达,但差异无统计学意义(P〉0.05)。结论MMP-2及MMP-9的阳性表达与TCCB的恶性程度及侵袭转移有关,可作为判断膀胱肿瘤预后的有用指标。 Objective To evaluate the expression of MMP-2 and MMP-9 and their relation with tumor invasion and metastasis in transitional cell carcinoma of bladder (TCCB). Methods Immunohistochemistry of EliVision were respectively used to determine the MMP-2 and MMP-9 expression in tumor tissues of 46 patients with TCCB and 14 cases of control group which were screened quantitatively (3-5 cm of surrounding tumor) between August 2006 and August 2008. Results Expression of MMP-2 and MMP-9 in TCCB are obviously higher than the normal control group (P 〈0.01), expressions of MMP-2 and MMP-9 in level Ⅱ, m are obviously higher than in level Ⅰ (P 〈0.01), but there was no significant relationship between high stage or level Ⅲ and low stage or level Ⅱ (P 〉0.05). Conclusion The positive expressions of MMP-2 and MMP-9 in tumor tissues correlated with the malignant degree, invasion and metastasis of TCCB, MMP-2, MMP-9 could be useful indicators for the assessment of prognosis of TCCB.
出处 《肿瘤研究与临床》 CAS 2009年第10期680-682,共3页 Cancer Research and Clinic
关键词 膀胱肿瘤 基质金属蛋白酶-2 基质金属蛋白酶-9 免疫组织化学 Urinary bladder neoplasms Matrix metalloproteinase-2 Matrix metalloproteinase-9 Immunohistoehemistry
  • 相关文献

参考文献2

二级参考文献13

  • 1万远廉,戎龙,刘玉村,汪欣,吴涛,潘义生,姚宏伟,叶京明,汤坚强,朱静.组织因子对大肠癌侵袭能力的影响及其与基质金属蛋白酶-9的关系[J].中华实验外科杂志,2004,21(9):1087-1088. 被引量:17
  • 2程波,仇登波,帅晓明,李治.乳腺癌中HER2基质金属蛋白酶-2和9的表达及其相互关系[J].中华实验外科杂志,2004,21(12):1513-1514. 被引量:9
  • 3Elisa CW,Rodrigo FC,Lance AL.General mechanisms of metastasis,1997,80:1529-1537.
  • 4Schwarzbauer J.Basement membranes:Putting up the barriers[J].Curr Boil,1999,9(7):R242-R244.
  • 5Koyama H,Iwata H,Kuwabara Y,et al.Gelatinolytic activity of matrix metalloproteinase-2 and -9 in oesophagealcarcinoma; a study using in situ zymography[J].Eur J Cancer,2000,36(16):2164-2170.
  • 6Dohadwala M,Batra R K,Luo J,et al.Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion[J].J Biol Chem,2002,277(52):50828-50833.
  • 7Sivula A,Talvensaari-Mattila A,Lundin J,et al.Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer[J].Breast Cancer Res Treat,2005,89(3):215-220.
  • 8Pan M R,Chuang L Y,Hung W C.Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells[J].FEBS Lett,2001,508(3):365-368.
  • 9Tsujii M,Kawano S,DuBois R N.Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential[J].Proc Natl Acad Sci USA,1997,94(7):3336-3340.
  • 10Cipollone F,Fazia M,Iezzi A,et al.Blockade of the angiotensin Ⅱ type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity[J].Circulation,2004,109(12):1482-1488.

共引文献38

同被引文献19

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部